Analyst Ratings for Stemline Therapeutics (STML) [Buys]
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/24/2019 | Cantor Fitzgerald » Updated 3/27/2020 |
Alethia Young | New Coverage | Overweight (N/A) |
10.00 (18.00) |
10.49 (11.83) |
12.77% | Details |
| 5/24/2019 | Roth/MKM | Jerry Issacson | New Coverage | Buy (N/A) |
33.00 (N/A) |
15.13 (11.83) |
-21.81% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
